anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

220,261-220,320 of 319,975

filter-aware
09
The slide uses a 2x3 grid layout to present six distinct ESG metrics and goals.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
11
The table provides a bridge between GAAP guidance ranges and specific adjustments like acquisition-related expenses, restructuring, and stock-based compensation.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
12
The table provides a bridge between GAAP guidance and specific adjustments like acquisition-related experiences, deferred revenue, and stock-based compensation.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
13
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
14
The slide provides specific FX rate assumptions for EUR, GBP, CAD, and SEK, and outlines the impact of a 10% USD strengthening on net bookings and operating expenses.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Visualization1 hit
15
The slide presents two separate tables for Q3 and full-year periods, detailing reported vs. constant currency growth rates.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Visualization1 hit
16
The slide contains two distinct tables: one by platform (Console, PC & other, Mobile) and one by revenue type (Full game, Live services & other).Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Action1 hit
17
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
02
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
03
The slide is a full-bleed image used to celebrate a company milestone.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a background image of an Eos energy storage container.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Need1 hit
05
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a timeline-based roadmap for high-level goals and a structured table for operational improvements.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a structured process-improvement framework to demonstrate operational maturity.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
09
Includes a process timeline and specific investment breakdown for capacity expansion.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
10
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
11
Includes a timeline at the bottom and specific financial/operational metrics.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
12
The slide uses a timeline-based visual to explain capacity scaling and financial viability.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
13
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
14
The slide uses a comparison frame to contrast summer and winter peak demand profiles, highlighting the inadequacy of 4-hour storage for winter needs.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
15
The slide uses a process flow for the utility side and a stakeholder/financing flow for the developer side.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
16
The slide uses a funnel-like progression from lead generation to backlog.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
17
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
18
The slide uses a waterfall-style comparison for Revenue and COGS to emphasize the year-over-year decline.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a green-themed sidebar for upcoming events and a structured table for KPI performance.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
02
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
03
Uses a hub-and-spoke diagram to represent the company's strategic pillars.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a Gantt-style visualization for drug development stages.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Golden Circle1 hit
05
This is a section divider or introductory slide for the product solution.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Includes specific financial breakdown of deal value and R&D funding obligations.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a side-by-side comparison structure to detail trial status and upcoming milestones for two distinct clinical programs.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
08
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
09
Includes a diagram illustrating cytokine-receptor binding and downstream signaling.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem in drug development.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
12
The slide uses a hub-and-spoke visual metaphor to explain the shared signaling mechanism of the γC receptor family.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
13
The slide uses a process diagram to show the transition from native cytokine sequences to a proprietary composite sequence, resulting in an engineered inhibitor.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
14
The slide uses a biological mechanism diagram to illustrate how the inhibitor selectively targets specific cytokines (A, D, F) while leaving others unaffected.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
15
The slide uses a visual mechanism to show how different inhibitors interact with cell signaling pathways.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
16
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
17
The slide uses a four-column structure to explain the target, the molecule, the preclinical results, and the clinical results.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
18
The slide uses a column-based layout to compare four distinct disease indications.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
19
The slide uses Western blot data to visually demonstrate the efficacy of EQ101 compared to a standard JAK inhibitor.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
20
Includes before/after clinical photos and a comparative table against Mogamulizumab.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
21
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a circular process diagram to show the feedback loop of immune cells and cytokines attacking the hair follicle.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
23
Includes visual longitudinal study (Day 0, 14, 21) and a bar chart comparing efficacy against PBS and Ruxolitinib.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
24
The slide compares two different drugs (baricitinib and deuruxolitinib) using two different chart types (line chart with negative values vs line chart with positive values) to demonstrate efficacy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
25
Includes a specific callout for a Blackbox warning on existing competitors.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Includes a timeline-style process diagram for the study phases.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
27
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
28
The slide uses a four-column layout to explain the target, the molecule structure, the mechanism of action, and the current clinical status.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
29
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
30
Includes a biological process diagram and a gene expression heatmap.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
31
The slide uses a biological pathway diagram and a bar chart to demonstrate efficacy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
32
The slide uses a process-like diagram to show treatment approaches and highlights the specific mechanism of action (IL-15/IL-21 inhibition) as a superior strategy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit